Transcriptional profiling in cancer: the path to clinical pharmacogenomics.
about
Analyzing microarray data using cluster analysis.Integration of molecular diagnostics with therapeutics: implications for drug discovery and patient care.Systems biology in drug safety and metabolism: integration of microarray, real-time PCR and enzyme approaches.Advances in the treatment for haematological malignancies.Pharmacogenomics and personalised medicine. SMI Conference on Pharmacogenomics and Personalised Medicine, 26-28 September, 2001, The Hatton, London, UK.
P2860
Transcriptional profiling in cancer: the path to clinical pharmacogenomics.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Transcriptional profiling in cancer: the path to clinical pharmacogenomics.
@ast
Transcriptional profiling in cancer: the path to clinical pharmacogenomics.
@en
Transcriptional profiling in cancer: the path to clinical pharmacogenomics.
@nl
type
label
Transcriptional profiling in cancer: the path to clinical pharmacogenomics.
@ast
Transcriptional profiling in cancer: the path to clinical pharmacogenomics.
@en
Transcriptional profiling in cancer: the path to clinical pharmacogenomics.
@nl
prefLabel
Transcriptional profiling in cancer: the path to clinical pharmacogenomics.
@ast
Transcriptional profiling in cancer: the path to clinical pharmacogenomics.
@en
Transcriptional profiling in cancer: the path to clinical pharmacogenomics.
@nl
P2860
P356
P1433
P1476
Transcriptional profiling in cancer: the path to clinical pharmacogenomics
@en
P2093
P2860
P304
P356
10.1517/14622416.2.2.123
P577
2001-05-01T00:00:00Z